Here’s the skinny (skimmed from The Motley Fool):
One: The highly anticipated legalization of recreational marijuana use in Canada this summer.
Two: The FDA approves GW Pharmaceutical’s Epidiolex, a cannabis-based drug for childhood epilepsy.
Three: Gallup poll suggesting the “last” group opposing marijuana—that is, seniors—are now softening up to medical and recreational marijuana use.
Well, that’s the skinny.
The risk of loss in the trading of stocks, options, futures, foreign exchanges, foreign equities, and bonds can be substantial and is not suitable for all investors. Trading on margin or the use of leverage is not suitable for all investors and losses exceeding your initial deposit is possible. Supporting documentation is available upon request. Trading futures, options on futures, and foreign exchanges involves substantial risk of loss and is not suitable for all investors. Carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources and only risk capital should be used. Opinions, market data, and recommendations are subject to change at any time. The lower the margin used the higher the leverage and therefore increases your risk. Past performance is not necessarily indicative of future results.